Publication
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Downloadable Content
- Persistent URL
- Last modified
- 05/15/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2020-07-03
- Publisher
- American Association for the Advancement of Science
- Publication Version
- Copyright Statement
- © 2020 American Association for the Advancement of Science. All rights reserved.
- Final Published Version (URL)
- Title of Journal or Parent Work
- Volume
- 369
- Issue
- 6499
- Start Page
- 49
- End Page
- +
- Grant/Funding Information
- This work was supported by The Marcus Foundation; Lustgarten Foundation for Pancreatic Cancer Research; The Virginia and D.K. Ludwig Fund for Cancer Research;
- The Sol Goldman Center for Pancreatic Cancer Research; Susan Wojcicki and Dennis Troper; the Rolfe Foundation; The Conrad R. Hilton Foundation;
- The John Templeton Foundation; Burroughs Wellcome Career Award For Medical Scientists; ancillary support to investigators was provided by National Institutes of Health grants and contracts CA06973, U01-CA152753, U01-CA230691, P50-CA62924, R44CA203350, R37CA230400, T32-GM007309, and HHSN261201600034C.
- Supplemental Material (URL)
- Abstract
- Cancer treatments are often more successful when the disease is detected early. We evaluated the feasibility and safety of multicancer blood testing coupled with positron emission tomography-computed tomography (PET-CT) imaging to detect cancer in a prospective, interventional study of 10,006 women not previously known to have cancer. Positive blood tests were independently confirmed by a diagnostic PET-CT, which also localized the cancer. Twenty-six cancers were detected by blood testing. Of these, 15 underwent PET-CT imaging and nine (60%) were surgically excised. Twenty-four additional cancers were detected by standard-of-care screening and 46 by neither approach. One percent of participants underwent PET-CT imaging based on false-positive blood tests, and 0.22% underwent a futile invasive diagnostic procedure. These data demonstrate that multicancer blood testing combined with PET-CT can be safely incorporated into routine clinical care, in some cases leading to surgery with intent to cure.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Pathology
- Biology, Biostatistics
- Biology, Bioinformatics
- Health Sciences, Oncology
- Biology, Neuroscience
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - vq37k.pdf | Primary Content | 2025-05-05 | Public | Download |